BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34115714)

  • 1. Preclinical Safety of a 3D-Printed Hydroxyapatite-Demineralized Bone Matrix Scaffold for Spinal Fusion.
    Plantz M; Lyons J; Yamaguchi JT; Greene AC; Ellenbogen DJ; Hallman MJ; Shah V; Yun C; Jakus AE; Procissi D; Minardi S; Shah RN; Hsu WK; Hsu EL
    Spine (Phila Pa 1976); 2022 Jan; 47(1):82-89. PubMed ID: 34115714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model.
    Plantz MA; Minardi S; Lyons JG; Greene AC; Ellenbogen DJ; Hallman M; Yamaguchi JT; Jeong S; Yun C; Jakus AE; Blank KR; Havey RM; Muriuki M; Patwardhan AG; Shah RN; Hsu WK; Stock SR; Hsu EL
    Acta Biomater; 2021 Jun; 127():146-158. PubMed ID: 33831576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
    Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
    Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-Printed Ceramic-Demineralized Bone Matrix Hyperelastic Bone Composite Scaffolds for Spinal Fusion.
    Driscoll JA; Lubbe R; Jakus AE; Chang K; Haleem M; Yun C; Singh G; Schneider AD; Katchko KM; Soriano C; Newton M; Maerz T; Li X; Baker K; Hsu WK; Shah RN; Stock SR; Hsu EL
    Tissue Eng Part A; 2020 Feb; 26(3-4):157-166. PubMed ID: 31469055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
    J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
    J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
    Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
    J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion.
    Cottrill E; Pennington Z; Wolf MT; Dirckx N; Ehresman J; Perdomo-Pantoja A; Rajkovic C; Lin J; Maestas DR; Mageau A; Lambrechts D; Stewart V; Sciubba DM; Theodore N; Elisseeff JH; Witham T
    J Neurosurg Spine; 2023 Jul; 39(1):113-121. PubMed ID: 37021767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
    Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
    J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the host response to rhBMP-2 in a rat spinal arthrodesis model.
    Hsu WK; Polavarapu M; Riaz R; Larson AC; Diegmueller JJ; Ghodasra JH; Hsu EL
    Spine (Phila Pa 1976); 2013 May; 38(12):E691-8. PubMed ID: 23429681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Geometry and Architecture on the
    Hallman M; Driscoll JA; Lubbe R; Jeong S; Chang K; Haleem M; Jakus A; Pahapill R; Yun C; Shah R; Hsu WK; Stock SR; Hsu EL
    Tissue Eng Part A; 2021 Jan; 27(1-2):26-36. PubMed ID: 32098585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented demineralized bone matrix: a potential alternative for posterolateral lumbar spinal fusion.
    Biswas D; Bible JE; Whang PH; Miller CP; Jaw R; Miller S; Grauer JN
    Am J Orthop (Belle Mead NJ); 2010 Nov; 39(11):531-8. PubMed ID: 21623419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterolateral lumbar fusion using Escherichia coli-derived rhBMP-2/hydroxyapatite in the mini pig.
    Kong CB; Lee JH; Baek HR; Lee CK; Chang BS
    Spine J; 2014 Dec; 14(12):2959-67. PubMed ID: 24937799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD; Carreon LY; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2843-9. PubMed ID: 19092613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
    Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
    J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
    Glassman SD; Dimar JR; Carreon LY; Campbell MJ; Puno RM; Johnson JR
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1694-8. PubMed ID: 16094268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.